28 Jul Madison startup Invenra lands partnership with Merck
Invenra, a Madison startup involved in the race to find drugs that will beat cancer, says it is teaming with Merck, one of the world’s leading pharmaceutical companies.
Invenra said it is collaborating with Merck to find the best antibodies for treating “an unnamed target of interest to Merck.” The two sides are not saying what that disease target is or how much money Invenra will receive from the global health care giant.
“We are excited to be working with this first-rate team in Merck,” said Roland Green, Invenra co-founder and CEO.
Invenra has developed a portfolio of antibodies, or proteins produced by the immune system to fight diseases. “We have replicated the human immune system antibody repertoire in a tube,” Green said.
Sorry, the comment form is closed at this time.